Imel Biotherapeutics develops cell-based therapies to treat patients with mitochondrial disorders. It uses a proprietary mitochondrial replaced cells technology, helping physicians to treat multiple patients with mitochondrial genetic or age-related disorders.The company was founded in 2019 and is b... Read more
This company has no teams yet